Julie Swanger works with both pediatric and adult sickle cell populations through Presbyterian Community Care Services and Blume Pediatric Hematology and Oncology Clinic in Charlotte, N.C.
References
- Conlan M. Therapeutic interventions frequent among hospital pharmacists. Drug Top Hosp Pharmacist Rep. 2000;14(9):38-39.
- Piturro M. Top PICS: Presbyterian Inpatient Care Specialists bring high-quality hospitalist care to North Carolina. The Hospitalist. 2006;01(10):23-25.
- Elander J, Midence K. A review of evidence about factors affecting quality of pain management in sickle cell disease. Clin J Pain. 1996 Sep;12(3):180-193.
- Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021-1030.
- Sickle Cell Disease Association of America, Inc., Web site. Outpatient management issues in sickle cell disease. Available at: www.sicklecelldisease.org/research/scd_manage3.phtml. Last accessed January 26, 2007.
- Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood. 2000 Feb;95(4):1130-1136.
- Pauling L, Itano HA, Singer SJ, et al. Sickle cell anemia a molecular disease. Science. 1949 Nov 25;110:543-548.
- Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature. 1957 Aug 17;180(4581):326-328.
- Thomas L. The technology of medicine. In: The Lives of a Cell. New York: Viking Press; 1974:31-36.
- Okpala IE. New therapies for sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct;19(5):975-987.